H1 Blog

JUNE 7, 2023

Clinical trial success is a key factor for pharma companies when designing and recruiting patients into trials. Fox Foundation will use Trial Landscape to streamline its search for physicians who are actively treating Parkinson’s disease and gather comprehensive information on their patient populations and treatment approaches.

Trials 52

Trials Clinical Trials Pharma Companies Clinical Development 52

H1 Blog

DECEMBER 11, 2024

While this approach aims to improve ROI before potential price controls kick in, it complicates trial design and recruitment, increasing the time it takes to get treatments to market. Furthermore, as pharma looks to offset future price controls, the prices of new drugs will likely spike.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

H1 Blog

MAY 4, 2023

A recent study found that physicians who use Twitter and other social media outlets are more likely to follow patient-centered approaches when it comes to choosing the best treatment for their patients. According to the study, 41% of doctors think social media influences prescribing behavior.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

H1 Blog

JULY 5, 2023

To learn more about how H1 can help diversify your HCP engagement strategy, request a demo. To ensure successful recruitment of these patients into clinical trials, medical affairs teams should consider providing translated materials (e.g.,

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

H1 Blog

MARCH 27, 2023

These conversations also open up dialogue for deeper understanding of patient outcomes and long-term effects of different treatments. By leveraging these educational platforms, MSLs can help amplify both positive brand messaging as well as emerging science around treatments that have yet to reach mainstream adoption for prescribers.

Science 52

Science Pharma Companies Pharmaceutical Companies Treatment 52